List of Tables
Table 1. Global Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Subretinal
Table 3. Key Players of Intravitreal
Table 4. Global Gene Therapy for Age-related Macular Degeneration Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy for Age-related Macular Degeneration Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy for Age-related Macular Degeneration Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gene Therapy for Age-related Macular Degeneration Market Share by Region (2018-2023)
Table 8. Global Gene Therapy for Age-related Macular Degeneration Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy for Age-related Macular Degeneration Market Share by Region (2024-2029)
Table 10. Gene Therapy for Age-related Macular Degeneration Market Trends
Table 11. Gene Therapy for Age-related Macular Degeneration Market Drivers
Table 12. Gene Therapy for Age-related Macular Degeneration Market Challenges
Table 13. Gene Therapy for Age-related Macular Degeneration Market Restraints
Table 14. Global Gene Therapy for Age-related Macular Degeneration Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gene Therapy for Age-related Macular Degeneration Market Share by Players (2018-2023)
Table 16. Global Top Gene Therapy for Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Age-related Macular Degeneration as of 2022)
Table 17. Ranking of Global Top Gene Therapy for Age-related Macular Degeneration Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene Therapy for Age-related Macular Degeneration Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy for Age-related Macular Degeneration Product Solution and Service
Table 21. Date of Enter into Gene Therapy for Age-related Macular Degeneration Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy for Age-related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share by Type (2018-2023)
Table 25. Global Gene Therapy for Age-related Macular Degeneration Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy for Age-related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share by Application (2018-2023)
Table 29. Global Gene Therapy for Age-related Macular Degeneration Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share by Application (2024-2029)
Table 31. North America Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 46. RetroSense Therapeutics Company Detail
Table 47. RetroSense Therapeutics Business Overview
Table 48. RetroSense Therapeutics Gene Therapy for Age-related Macular Degeneration Product
Table 49. RetroSense Therapeutics Revenue in Gene Therapy for Age-related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 50. RetroSense Therapeutics Recent Development
Table 51. REGENXBIO Company Detail
Table 52. REGENXBIO Business Overview
Table 53. REGENXBIO Gene Therapy for Age-related Macular Degeneration Product
Table 54. REGENXBIO Revenue in Gene Therapy for Age-related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 55. REGENXBIO Recent Development
Table 56. AGTC Company Detail
Table 57. AGTC Business Overview
Table 58. AGTC Gene Therapy for Age-related Macular Degeneration Product
Table 59. AGTC Revenue in Gene Therapy for Age-related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 60. AGTC Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy for Age-related Macular Degeneration Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gene Therapy for Age-related Macular Degeneration Market Share by Type: 2022 VS 2029
Figure 3. Subretinal Features
Figure 4. Intravitreal Features
Figure 5. Global Gene Therapy for Age-related Macular Degeneration Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gene Therapy for Age-related Macular Degeneration Market Share by Application: 2022 VS 2029
Figure 7. Monotherapy Case Studies
Figure 8. Combination Therapy Case Studies
Figure 9. Gene Therapy for Age-related Macular Degeneration Report Years Considered
Figure 10. Global Gene Therapy for Age-related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Gene Therapy for Age-related Macular Degeneration Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Gene Therapy for Age-related Macular Degeneration Market Share by Region: 2022 VS 2029
Figure 13. Global Gene Therapy for Age-related Macular Degeneration Market Share by Players in 2022
Figure 14. Global Top Gene Therapy for Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Age-related Macular Degeneration as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy for Age-related Macular Degeneration Revenue in 2022
Figure 16. North America Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Gene Therapy for Age-related Macular Degeneration Market Share by Country (2018-2029)
Figure 18. United States Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Gene Therapy for Age-related Macular Degeneration Market Share by Country (2018-2029)
Figure 22. Germany Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Share by Region (2018-2029)
Figure 30. China Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Gene Therapy for Age-related Macular Degeneration Market Share by Country (2018-2029)
Figure 38. Mexico Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Share by Country (2018-2029)
Figure 42. Turkey Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. RetroSense Therapeutics Revenue Growth Rate in Gene Therapy for Age-related Macular Degeneration Business (2018-2023)
Figure 45. REGENXBIO Revenue Growth Rate in Gene Therapy for Age-related Macular Degeneration Business (2018-2023)
Figure 46. AGTC Revenue Growth Rate in Gene Therapy for Age-related Macular Degeneration Business (2018-2023)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed